← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 16, 2024Last known activity
Nov 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 14 trials)
Phase 2 (11 own, 0 via acquisition)
Recent trials (14)
- NCT07221760Lead sponsorPhase 1/Phase 2Nov 30, 2025
- NCT07226297Lead sponsorPhase 1/Phase 2Oct 27, 2025
- NCT07177196Lead sponsorPhase 1/Phase 2Aug 28, 2025
- NCT07197268Lead sponsorPhase 1/Phase 2May 19, 2025
- NCT06816498Lead sponsorPhase 1/Phase 2Mar 17, 2025
- NCT07197294Lead sponsorPhase 1/Phase 2Feb 24, 2025
- NCT07095712Lead sponsorPhase 1/Phase 2Nov 25, 2024
- NCT07084311Lead sponsorPhase 1/Phase 2Oct 24, 2024
- NCT07095686Lead sponsorPhase 1/Phase 2Oct 2, 2024
- NCT06369974CollaboratorPhase 1/Phase 2Jun 30, 2024
- NCT06977451Lead sponsorPhase 1/Phase 2Jun 24, 2024
- NCT06392126Lead sponsorPhase 1/Phase 2Apr 16, 2024
- NCT06706388Lead sponsorPhase 1/Phase 2Feb 21, 2024
- NCT06314490CollaboratorPhase 1/Phase 2Feb 16, 2024
Details
- Last known activity
- Nov 30, 2025